USA – CDER approved 50 novel drugs in 2024, record number of biosimilars
In 2024, CDER approved 50 new drugs never before approved or marketed in the U.S., known as “novel” drugs. We also made other important approval decisions, such as approving previously approved drugs for new uses and broader patient populations. CDER’s novel drug approvals for 2024 are listed here.
More information can be found in the CDER report.
OpenEdition vous propose de citer ce billet de la manière suivante :
vroby (25 mars 2025). USA – CDER approved 50 novel drugs in 2024, record number of biosimilars. ELSIBI. Consulté le 19 janvier 2026 à l’adresse https://doi.org/10.58079/13kgh





